Hong Kong IPO disclosure precedents · 80 companies, 82 items
One product line, product category or end-market/application is the largest revenue source, with its demand trends, pricing and margins driving overall results, including cases where diversification is gradually reducing the concentration.
As of December 31, 2022, 2023 and 2024, we had 5,244, 7,756 and 9,152 franchised stores, revenue from which accounted for 94.3%, 96.3% and 96.5% of our total revenue in 2022, 2023 and 2024.
Financial Information · p. 250
In 2022, 2023 and 2024, revenue from sales of goods to franchisees accounted for 82.4%, 82.9% and 83.1% of our revenue from our franchising operations, respectively.
Financial Information · p. 250
The performance of our franchised stores strongly affects their procurement volume with us, which in turn affects our results of operations.
The number of our customer decreased from 92 in 2023 to 81 in 2024, which was primarily because (i) in 2024, our production capacity was insufficient to fulfill orders from smaller customers, resulting in a decline in the number of smaller customers; and (ii) we prioritized allocating resources to automotive OEM customers to maximize efficiency and revenue contribution, as a result of our shift in focus to the EV battery business, the core customers of which are OEM customers.
Summary · p. 10
Additionally, in 2023, as we disposed of down-grade products as a result of the WM Customer Incident, amounting to RMB173.1 million, we had additional revenue from other products and services, while such revenue decreased significantly in 2024, leading to an increase in the proportion of revenue from OEM customers in 2024.
For FY2021, FY2022, FY2023, 9M2023 and 9M2024, sales of oil accounted for (i) approximately 74.6%, 73.4%, 70.0%, 72.3% and 73.2% of our revenue from sales of food under our wholesales, respectively; and (ii) approximately 67.7%, 62.8%, 64.2%, 67.5% and 68.2% of our revenue from wholesales, respectively.
Summary · p. 2
As an illustration of the significance of our collaboration with Yihai Kerry to the growth of our wholesale operations, our revenue from sales of oil under our wholesales increased significantly from approximately RMB311.0 million for FY2022 to approximately RMB436.1 million for FY2023, and increased significantly from approximately RMB293.3 million for 9M2023 to approximately RMB387.6 million for 9M2024.
During the Track Record Period, our revenue from general sales in Malls was substantially contributed by Jiangdu Mall* (江都商城), which accounted for over 95% of our revenue from general sales in Malls.
Business · p. 241
Overall, the entire Jiangdu Mall contributed an aggregate of approximately 13.4%, 7.9%, 9.9%, and 9.9% to our total revenue for each of FY2021, FY2022, FY2023 and 9M2024, respectively.
Babycare products, including baby diapers, baby pants, and, to a lesser extent, baby wipes, are particularly significant, accounting for approximately 86.8%, 78.9%, 71.5%, 78.9% and 55.0% of our revenue during the Track Record Period.
Financial Information · p. 274
Among our revenue from Contract Manufacturing which was primarily generated in Eurasia, approximately 94.5%, 98.8%, 98.3%, and 87.8% were attributable to the sale of our babycare products
Summary · p. 3
During the Track Record Period, profitability varies among the three main product categories particularly, babycare and adult incontinence products generally offered lower gross profit margins compared to feminine care products. The product mix significantly affects overall profitability.
During the Track Record Period, we derived a large portion of revenue from PHC Services, which amounted to RMB215.6 million in 2021, RMB298.1 million in 2022, RMB239.8 million in 2023, RMB87.0 million in the six months ended June 30, 2023 and RMB55.0 million in the six months ended June 30, 2024, accounting for 57.9%, 63.2%, 43.1%, 44.7% and 24.0% of our total revenue in 2021, 2022 and 2023 and the six months ended June 30, 2023 and 2024, respectively.
Business · p. 205
While these policies do not prohibit bulk purchases, they prompted the government entities to adopt a more stringent procurement process for high-value contracts and resulted in a deceleration in the procurement and contract finalization process since the end of 2022 to early 2024.
Business · p. 205
Following this additional sales strategy, the revenue recognized from the county, district and community-level customers increased by 42.6% from RMB67.2 million in 2022 to RMB95.8 million in 2023 despite the overall decrease in revenue from our PHC Services from 2022 to 2023.
revenue from six-axis cobots accounted for 14.9%, 43.5%. 46.8%, 47.9% and 53.0% of our total revenue in 2021, 2022, 2023 and the six months ended June 30, 2023 and 2024, respectively, and revenue from four-axis cobots accounted for 68.8%, 41.9%, 34.7%, 36.8% and 30.5% of our total revenue in the same years/periods, respectively.
Revenue generated from our automotive solutions contributed a vast majority of our total revenue, accounting for 87.9%, 88.5%, 94.8%, 92.9% and 97.7% of total revenue in 2021, 2022 and 2023 and for the six months ended June 30, 2023 and 2024, respectively.
Summary · p. 16
Revenue mix from different revenue sources affect our profitability.
Financial Information · p. 377
In addition, we provided non-automotive solutions to our customers during the Track Record Period, the gross profit margin of which was generally lower than that of our automotive solutions.
revenue from autonomous driving products and solutions increased from RMB34.3 million in 2021 to RMB142.3 million in 2022, and further to RMB276.3 million in 2023, accounting for 56.6%, 86.0% and 88.5% of our total revenue for the same years, respectively;
Summary · p. 25
With further penetration and development of the autonomous driving products and solutions market, we expect that our revenue from such products and solutions will continue to grow significantly and be our major revenue contributor in the foreseeable future.
Revenue from customers in the semiconductor industry slightly decreased from approximately S$35.7 million for the year ended 31 December 2022 to approximately S$34.1 million for the year ended 31 December 2023.
Summary · p. 12
During the Track Record Period, a significant portion of our revenue was derived from our major customers in the semiconductor manufacturing equipment industry. Therefore, our financial performance and future growth depend on the overall growth of the global semiconductor industry.
Financial Information · p. 285
We have made consistent efforts to strategically diversify our business into other downstream industries including aerospace and data storage industries, through which we can solicit more business opportunities and provide more diversified services.
For the years ended December 31, 2021, 2022 and 2023, sales of toluene oxidation products and toluene chlorination products comprised 64.5%, 76.1% and 72.6% of our total revenue, respectively.
Financial Information · p. 259
According to the Frost & Sullivan Report, our Group ranked as the largest manufacturer for both benzoic acid and sodium benzoate and the second largest benzyl alcohol manufacturer in the PRC in terms of the sales revenue in 2023, representing 62.0%, 37.9% and 33.9% of the PRC total market revenue in 2023, respectively.
During the Track Record Period, our total revenue in the IDC Solution Services segment surged from RMB437.2 million in 2021 to RMB673.8 million in 2023 at a CAGR of 24.1%.
Summary · p. 1
During the Track Record Period, our revenue from our ICT Services and Other Services decreased from 5.8% of our total revenue in 2021 to 0.9% of our total revenue in 2022 and further to 0.6% of our total revenue in the year ended 31 December 2023.
Financial Information · p. 346
Our Edge Computing Services generally provide higher gross profits margin as compared to our IDC Solution Services, primarily attributable to higher average selling prices.
During the Track Record Period, substantially all of our revenue from drug discovery solutions were generated from our small molecule discovery solutions.
Business · p. 405
We started recording revenue from our antibody discovery solutions in 2022, and generated a total revenue of RMB10.3 million during the Track Record Period (i.e. in 2022 and 2023), representing approximately 5.9% of our total revenue from drug discovery solutions in 2022 and 2023, accumulatively.
Business · p. 405
we expect to generate meaningful amounts of revenue from our antibody drug discovery business from 2024 and onward.
During the Track Record Period, we have generated the majority of our revenue from provision of imaging center services.
Summary · p. 3
Our revenue generated from the imaging center services was RMB442.3 million, RMB497.7 million and RMB638.1 million, respectively, in 2021, 2022 and 2023 growing at a CAGR of 20.1% from 2021 to 2023, despite the impact of the COVID-19 pandemic in the same years.
Gaming revenue is the major revenue source of our Group which accounted for approximately 70% of our total revenue for each of the three years ended 31 March 2023 and the six months ended 30 September 2023.
Summary · p. 10
For the three years ended 31 March 2023 and the six months ended 30 September 2022 and 2023, our gaming revenue represented 74.0%, 79.3%, 73.8%, 71.5% and 69.8% of our total revenue, respectively.
Summary · p. 20
In contrast, border casinos primarily target players from neighbouring countries rather than local residents and they tend to have a lesser impact on their local communities.
We have been focusing mainly on municipal public construction works since our establishment and the increase of our revenue contribution from building construction related works for the year ended December 31, 2022 was mainly because we undertook 10 out of 11 building construction related projects in relation to the overall renovation and remodeling of the Tianjin municipal government subsidized apartments (the ‘‘Tianjiang Apartment Projects (天江公寓項目)’’) in the second half of 2022.
Business · p. 156
The Group therefore focused on and deployed most of its resources on the Tianjiang Apartment Projects (天江公寓項目) and undertook fewer projects of other construction types in 2022, leading to a significant increase in the revenue generated from building construction related works.
Business · p. 156
In 2022, we undertook 10 out of 11 of the Tianjiang Apartment Projects (天江公寓項目). Those 10 projects had an aggregate contract amount (exclude variation orders) of approximately RMB135.2 million.
During the Track Record Period, we primarily provided intralogistics equipment subscription services, which contributed 65.2%, 63.0%, 61.8% and 55.9% of the total revenue in 2020, 2021, 2022 and the four months ended April 30, 2023.
Summary · p. 1
To manage this business segment effectively, our ability to optimize equipment utilization rates while expanding our fleet to meet growing market demand is critical to our financial performance.
Financial Information · p. 306
Our management team proactively monitors and analyzes utilization rates to identify trends, areas for improvement, and expansion opportunities.
Our revenue from automobile retail and finance business contributed 79.7%, 86.4%, 87.4% and 88.7% of total revenue for the years ended 31 December 2020, 2021, 2022 and the six months ended 30 June 2023, respectively.
Financial Information · p. 335
Our revenue from sales of automobile under direct finance lease accounted for 98.9%, 99.7%, 99.8% and 99.95% of total revenue generated from our automobile retail and finance business for the years ended 31 December 2020, 2021, 2022 and the six months ended 30 June 2023, respectively.
Business · p. 181
We have a proven track record of successfully expanding our geographic footprint in tier two, tier three and below cities.
For the years ended 31 December 2020, 2021 and 2022 and the four months ended 30 April 2023, our revenue generated from services provided to customers in the education sector accounted for 82.8%, 57.2%, 81.3% and 83.8% of our total revenue, respectively.
Summary · p. 1
We consider the expansion to the government sector as diversification of our business operation.
Summary · p. 1
During the Track Record Period, we placed strategic focus on providing services to customers in the education sector.
We currently derive our revenue primarily from the sale of pharmaceuticals to buyers under our Selfoperation Business.
Financial Information · p. 244
Our gross profit margin declined from 10.0% in 2020 to 9.1% in 2021, primarily due to the expansion of our Self-operation Business, which generally has a lower gross profit margin than other businesses.
Summary · p. 17
Changes in mix of revenue from different sources could have a significant impact on our profitability. We intend to better manage the mix of our product and service offerings to improve our profitability.